169 related articles for article (PubMed ID: 26007739)
21. Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue.
Herrala AM; Porvari KS; Kyllönen AP; Vihko PT
Cancer; 2001 Dec; 92(12):2975-84. PubMed ID: 11753974
[TBL] [Abstract][Full Text] [Related]
22. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
Haese A; Graefen M; Becker C; Noldus J; Katz J; Cagiannos I; Kattan M; Scardino PT; Huland E; Huland H; Lilja H
Prostate; 2003 Feb; 54(3):181-6. PubMed ID: 12518322
[TBL] [Abstract][Full Text] [Related]
23. Porous silicon antibody microarrays for quantitative analysis: measurement of free and total PSA in clinical plasma samples.
Järås K; Adler B; Tojo A; Malm J; Marko-Varga G; Lilja H; Laurell T
Clin Chim Acta; 2012 Dec; 414():76-84. PubMed ID: 22921878
[TBL] [Abstract][Full Text] [Related]
24. Development of a high-sensitivity immunoassay for amyloid-beta 1-42 using a silicon microarray platform.
Gagni P; Sola L; Cretich M; Chiari M
Biosens Bioelectron; 2013 Sep; 47():490-5. PubMed ID: 23624018
[TBL] [Abstract][Full Text] [Related]
25. Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
Steuber T; Vickers AJ; Haese A; Becker C; Pettersson K; Chun FK; Kattan MW; Eastham JA; Scardino PT; Huland H; Lilja H
Int J Cancer; 2006 Mar; 118(5):1234-40. PubMed ID: 16152616
[TBL] [Abstract][Full Text] [Related]
26. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
[TBL] [Abstract][Full Text] [Related]
27. High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry.
Finnskog D; Jaras K; Ressine A; Malm J; Marko-Varga G; Lilja H; Laurell T
Electrophoresis; 2006 Mar; 27(5-6):1093-103. PubMed ID: 16523454
[TBL] [Abstract][Full Text] [Related]
28. Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.
Nam RK; Zhang WW; Trachtenberg J; Diamandis E; Toi A; Emami M; Ho M; Sweet J; Evans A; Jewett MA; Narod SA
J Clin Oncol; 2003 Jun; 21(12):2312-9. PubMed ID: 12805332
[TBL] [Abstract][Full Text] [Related]
29. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
[TBL] [Abstract][Full Text] [Related]
30. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
[TBL] [Abstract][Full Text] [Related]
31. New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease.
Stenman UH
Clin Chem; 1999 Jun; 45(6 Pt 1):753-4. PubMed ID: 10351981
[No Abstract] [Full Text] [Related]
32. Highly sensitive poly[glycidyl methacrylate-co-poly(ethylene glycol) methacrylate] brush-based flow-through microarray immunoassay device.
Liu Y; Wang W; Hu W; Lu Z; Zhou X; Li CM
Biomed Microdevices; 2011 Aug; 13(4):769-77. PubMed ID: 21547537
[TBL] [Abstract][Full Text] [Related]
33. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
Stephan C; Jung K; Nakamura T; Yousef GM; Kristiansen G; Diamandis EP
Int J Urol; 2006 Mar; 13(3):238-43. PubMed ID: 16643616
[TBL] [Abstract][Full Text] [Related]
34. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
[TBL] [Abstract][Full Text] [Related]
35. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
Slawin KM; Shariat SF; Nguyen C; Leventis AK; Song W; Kattan MW; Young CY; Tindall DJ; Wheeler TM
Cancer Res; 2000 Dec; 60(24):7142-8. PubMed ID: 11156423
[TBL] [Abstract][Full Text] [Related]
36. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
[TBL] [Abstract][Full Text] [Related]
37. Macroporous silicon based simple and efficient trapping platform for electrical detection of Salmonella typhimurium pathogens.
Das RD; RoyChaudhuri C; Maji S; Das S; Saha H
Biosens Bioelectron; 2009 Jul; 24(11):3215-22. PubMed ID: 19477111
[TBL] [Abstract][Full Text] [Related]
38. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.
Tremblay RR; Deperthes D; Têtu B; Dubé JY
Am J Pathol; 1997 Feb; 150(2):455-9. PubMed ID: 9033261
[TBL] [Abstract][Full Text] [Related]
40. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
